Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Soyka

Showing results (1-10 of 222) with videos related to

Pageof 23
Sort By:
Addiction (Abingdon, England)|November 11, 2010
To substitute or not substitute—optimal tactics for the management of benzodiazepine dependenceMichael Soyka
Addiction (Abingdon, England)|January 18, 2012
Dopamine is not dopamineMichael Soyka
Evidence-Based Mental Health|April 23, 2013
Review: In alcohol use disorders, acamprosate is more effective for inducing abstinence while naltrexone is more effective for reducing heavy drinking and cravingMichael Soyka
CNS Drugs|June 19, 2013
Buprenorphine use in pregnant opioid users: a critical reviewMichael Soyka
Expert Opinion on Drug Delivery|August 27, 2014
Buprenorphine-naloxone buccal soluble film for the treatment of opioid dependence: current updateMichael Soyka
Dialogues in Clinical Neuroscience|January 6, 2018
Treatment of opioid dependence with buprenorphine: current updateMichael Soyka
Pharmacopsychiatry|November 19, 2020
Novel Long-Acting Buprenorphine Medications for Opioid Dependence: Current UpdateMichael Soyka
Der Nervenarzt|June 19, 2023
[Paranoid hallucinatory psychosis following intoxication with fly agaric]Michael Soyka
The New England Journal of Medicine|March 23, 2017
Treatment of Benzodiazepine DependenceMichael Soyka
Schizophrenia Bulletin|August 24, 2011
Neurobiology of aggression and violence in schizophreniaMichael Soyka
Pageof 23

Showing results (1-10 of 222) with videos related to

Sort By:
Pageof 23
Addiction (Abingdon, England)|November 11, 2010
To substitute or not substitute—optimal tactics for the management of benzodiazepine dependenceMichael Soyka
Addiction (Abingdon, England)|January 18, 2012
Dopamine is not dopamineMichael Soyka
Evidence-Based Mental Health|April 23, 2013
Review: In alcohol use disorders, acamprosate is more effective for inducing abstinence while naltrexone is more effective for reducing heavy drinking and cravingMichael Soyka
CNS Drugs|June 19, 2013
Buprenorphine use in pregnant opioid users: a critical reviewMichael Soyka
Expert Opinion on Drug Delivery|August 27, 2014
Buprenorphine-naloxone buccal soluble film for the treatment of opioid dependence: current updateMichael Soyka
Dialogues in Clinical Neuroscience|January 6, 2018
Treatment of opioid dependence with buprenorphine: current updateMichael Soyka
Pharmacopsychiatry|November 19, 2020
Novel Long-Acting Buprenorphine Medications for Opioid Dependence: Current UpdateMichael Soyka
Der Nervenarzt|June 19, 2023
[Paranoid hallucinatory psychosis following intoxication with fly agaric]Michael Soyka
The New England Journal of Medicine|March 23, 2017
Treatment of Benzodiazepine DependenceMichael Soyka
Schizophrenia Bulletin|August 24, 2011
Neurobiology of aggression and violence in schizophreniaMichael Soyka
Pageof 23